AIM • KMU EXAM PRACTICE
KMU Past Paper Practice
Cephalosporins, Carbapenems, Monobactams and Other Cell-Wall Active Antibiotics
3rd Year MBBS • 20 A-type Single Best Answer MCQs
MCQ 1
Question:
A 58-year-old man undergoes elective abdominal surgery in which contamination by bowel flora is anticipated. The surgical team selects a cephalosporin with useful activity against selected anaerobic organisms. Which agent best fits this requirement?
Options:
Cefazolin
Ceftriaxone
Cefepime
Cefotetan
Ceftaroline
Correct Answer: Cefotetan
Explanation: Cefotetan is a cephamycin with useful activity against selected anaerobic organisms, making it relevant when anaerobic coverage is needed.
MCQ 2
Question:
A patient is discharged after improvement of a susceptible bacterial infection and is changed from parenteral therapy to an orally administered first-generation cephalosporin. Which drug is most suitable for this route?
Options:
Cefepime
Cephalexin
Ceftazidime
Cefotaxime
Cefazolin
Correct Answer: Cephalexin
Explanation: Cephalexin is an orally administered first-generation cephalosporin, whereas cefazolin is an important parenteral representative of the same generation.
MCQ 3
Question:
A clinician compares cephalosporin generations while selecting treatment for a gram-negative infection. Which general change best describes progression from first-generation to third-generation agents?
Options:
Progressive loss of all gram-positive activity
Increasing activity against anaerobes only
Increasing activity against gram-negative organisms
Progressive restriction to gram-positive organisms
Increasing activity against mycobacteria
Correct Answer: Increasing activity against gram-negative organisms
Explanation: The broad generational pattern is increasing gram-negative activity from earlier to later cephalosporins; later generations are not simply “stronger” versions of earlier drugs.
MCQ 4
Question:
A patient receiving a broad-spectrum cephalosporin develops diarrhea after several days of therapy. No immediate hypersensitivity features are present. Which pharmacological consequence most reasonably contributes to this complication?
Options:
Alteration of normal intestinal flora
Stimulation of gastric acid secretion
Inhibition of pancreatic enzyme release
Blockade of intestinal histamine receptors
Reduction of gastrointestinal motility
Correct Answer: Alteration of normal intestinal flora
Explanation: Broad antibacterial therapy can disturb normal intestinal flora, producing gastrointestinal disturbance and creating conditions for superinfection by resistant organisms.
MCQ 5
Question:
A hospitalized patient develops prolonged bleeding while receiving a cephalosporin with a side chain associated with impaired vitamin K-dependent coagulation. Which additional adverse effect is most closely associated with the same group of cephalosporins?
Options:
Gray baby syndrome
Severe tooth discoloration
Tendon rupture
Optic neuritis
Alcohol-associated flushing and nausea
Correct Answer: Alcohol-associated flushing and nausea
Explanation: Certain cephalosporins with characteristic side chains can impair vitamin K-dependent coagulation and also produce a disulfiram-like response after ethanol exposure.
MCQ 6
Question:
A patient previously developed an immediate allergic reaction to a penicillin. A cephalosporin is being considered for a new infection. Which property of the drug class is most relevant to this history?
Options:
Potential immunological cross-reactivity with penicillins
Obligatory inhibition of acetaldehyde metabolism
Selective toxicity toward auditory nerve fibers
Direct inhibition of bacterial folate synthesis
Preferential accumulation inside macrophages
Correct Answer: Potential immunological cross-reactivity with penicillins
Explanation: Penicillins and cephalosporins are beta-lactam antibiotics, and some immunological cross-reactivity can occur; the allergy history is therefore clinically relevant.
MCQ 7
Question:
A cephalosporin-sensitive organism is treated with a drug that reaches the site of infection but is cleared so rapidly that its free concentration falls below the MIC for most of the dosing interval. What is the most likely consequence?
Options:
Enhanced post-antibiotic activity
Improved concentration-dependent killing
Reduced antibacterial effectiveness
Increased activity against anaerobes
Conversion to bacteriostatic action
Correct Answer: Reduced antibacterial effectiveness
Explanation: Cephalosporin efficacy depends on maintaining free drug concentrations above the MIC for an adequate portion of the dosing interval.
MCQ 8
Question:
A patient with severe infection is started empirically on a carbapenem because both aerobic and anaerobic pathogens are possible. Which feature most directly supports this choice?
Options:
Selective gram-positive activity
Restriction to aerobic gram-negative bacilli
Exclusive activity against anaerobic bacteria
Broad aerobic and anaerobic antibacterial activity
Specific activity against MRSA
Correct Answer: Broad aerobic and anaerobic antibacterial activity
Explanation: Carbapenems cover many gram-positive, gram-negative and anaerobic organisms, explaining their role in severe infections where broad coverage is required.
MCQ 9
Question:
Culture from a serious infection grows a resistant gram-negative organism. The physician selects a beta-lactam that is relatively stable against many bacterial beta-lactamases and has very broad antibacterial coverage. Which class is being used?
Options:
First-generation cephalosporins
Carbapenems
Glycopeptides
Monobactams
Topical polypeptides
Correct Answer: Carbapenems
Explanation: Carbapenems combine exceptionally broad antibacterial activity with stability against many beta-lactamases, supporting their use in selected serious resistant infections.
MCQ 10
Question:
A patient has an infection caused solely by a susceptible aerobic gram-negative bacillus. The physician wants a beta-lactam with a narrow spectrum that avoids unnecessary gram-positive and anaerobic coverage. Which class best fits this strategy?
Options:
Carbapenems
Glycopeptides
First-generation cephalosporins
Cephamycins
Monobactams
Correct Answer: Monobactams
Explanation: The monobactam aztreonam provides focused activity against aerobic gram-negative bacteria without useful gram-positive or anaerobic coverage.
MCQ 11
Question:
A microbiology report identifies a susceptible anaerobic organism as the major pathogen. Aztreonam is available on the ward. Why would this drug be inappropriate as targeted monotherapy?
Options:
Its activity is limited mainly to aerobic gram-negative bacteria
Its activity is limited mainly to gram-positive cocci
Its activity is restricted to mycobacteria
Its action requires topical administration
Its action requires biliary elimination
Correct Answer: Its activity is limited mainly to aerobic gram-negative bacteria
Explanation: Aztreonam lacks useful activity against anaerobes and gram-positive organisms; its clinically relevant spectrum is aerobic gram-negative bacteria.
MCQ 12
Question:
A gram-negative organism is intrinsically poorly susceptible to vancomycin despite having peptidoglycan in its cell wall. Which structural feature best explains the limited activity of vancomycin against this organism?
Options:
Absence of peptidoglycan precursors
Absence of D-alanine residues
Rapid renal elimination of the organism
Poor penetration through the outer membrane
Inactivation by human plasma proteins
Correct Answer: Poor penetration through the outer membrane
Explanation: Vancomycin is a large molecule and penetrates the gram-negative outer membrane poorly, explaining why its antibacterial activity is mainly directed toward gram-positive organisms.
MCQ 13
Question:
Vancomycin is added to a culture of susceptible gram-positive bacteria. Peptidoglycan precursors accumulate, but normal cell-wall construction fails. Which process has been directly disrupted?
Options:
DNA supercoiling
Incorporation and cross-linking of peptidoglycan
Formation of bacterial folate
Translation at the 30S ribosome
Synthesis of bacterial RNA
Correct Answer: Incorporation and cross-linking of peptidoglycan
Explanation: By binding D-Ala-D-Ala on peptidoglycan precursors, vancomycin interferes with their incorporation and proper cross-linking during bacterial cell-wall formation.
MCQ 14
Question:
A patient receiving intravenous vancomycin for a serious gram-positive infection reports new difficulty hearing. Which recognized toxicity should be considered?
Options:
Hepatotoxicity
Cardiotoxicity
Retinal toxicity
Pancreatic toxicity
Ototoxicity
Correct Answer: Ototoxicity
Explanation: Ototoxicity is a recognized adverse effect of vancomycin and should be considered when auditory symptoms develop during therapy.
MCQ 15
Question:
A patient develops pain and inflammation along the vein during intravenous vancomycin treatment. There is no generalized flushing or hypotension. Which adverse effect best explains the localized finding?
Options:
Nephrotoxicity
Ototoxicity
Phlebitis
Superinfection
Coagulopathy
Correct Answer: Phlebitis
Explanation: Intravenous vancomycin can irritate the vein and produce phlebitis; localized venous pain and inflammation distinguish it from a systemic infusion reaction.
MCQ 16
Question:
A microbiologist compares vancomycin with cephalosporins. Both ultimately interfere with bacterial cell-wall formation, but their immediate molecular targets differ. Which statement best distinguishes vancomycin?
Options:
It inhibits DNA gyrase rather than cell-wall synthesis
It blocks folate synthesis rather than peptidoglycan formation
It binds ribosomal RNA rather than bacterial enzymes
It binds the peptidoglycan precursor rather than a PBP
It disrupts bacterial membranes rather than cell-wall synthesis
Correct Answer: It binds the peptidoglycan precursor rather than a PBP
Explanation: Vancomycin binds D-Ala-D-Ala on the peptidoglycan precursor, whereas cephalosporins exert their beta-lactam effect through penicillin-binding proteins.
MCQ 17
Question:
Three cell-wall active drugs are reviewed during ward teaching. One is useful for urinary infection, one is mainly topical because of toxicity, and one is reserved as a second-line antituberculous drug. Which sequence correctly matches these clinical roles?
Options:
Bacitracin – fosfomycin – cycloserine
Cycloserine – bacitracin – fosfomycin
Fosfomycin – cycloserine – bacitracin
Cycloserine – fosfomycin – bacitracin
Fosfomycin – bacitracin – cycloserine
Correct Answer: Fosfomycin – bacitracin – cycloserine
Explanation: Fosfomycin has an important role in susceptible uncomplicated UTI, bacitracin is mainly topical, and cycloserine is a second-line agent for resistant tuberculosis.
MCQ 18
Question:
A researcher compares three non-beta-lactam inhibitors of cell-wall synthesis. One drug prevents transport of peptidoglycan building blocks across the bacterial membrane. Which agent has this action?
Options:
Fosfomycin
Bacitracin
Cycloserine
Vancomycin
Aztreonam
Correct Answer: Bacitracin
Explanation: Bacitracin interferes with membrane transport of peptidoglycan precursors, helping explain its inhibition of bacterial cell-wall construction.
MCQ 19
Question:
A patient with a susceptible lower urinary tract infection is prescribed a cell-wall active drug that acts before the later steps targeted by beta-lactams. Which stage of bacterial cell-wall formation is principally affected by this drug?
Options:
Early synthesis of peptidoglycan precursors
Binding of peptidoglycan to PBP2a
Synthesis of bacterial ribosomal proteins
Replication of bacterial chromosomal DNA
Formation of bacterial folate cofactors
Correct Answer: Early synthesis of peptidoglycan precursors
Explanation: Fosfomycin inhibits an early step of peptidoglycan synthesis, distinguishing its site of action from beta-lactams that interfere with later cell-wall cross-linking.
MCQ 20
Question:
A student is asked to match the antibacterial drug with the feature that most strongly determines its clinical role. Which pairing is most accurate?
Options:
Aztreonam — broad gram-positive and anaerobic coverage
Vancomycin — effective penetration of gram-negative outer membrane
Bacitracin — routine systemic use because of low toxicity
Cephalexin — parenteral treatment requiring CSF penetration
Carbapenems — broad coverage for serious complicated infections
Correct Answer: Carbapenems — broad coverage for serious complicated infections
Explanation: Carbapenems combine broad gram-positive, gram-negative and anaerobic activity, which explains their important role in selected severe and complicated infections.